Silver Book Fact

Resolvins, a family of lipid mediators, have shown potential in resolving persistent inflammatory pain.

Xu, Zheng-Zhong, Ling Zhang, Tong Liu, John Yeon Park, Temugin Berta, Rong Yang, Charles N Sherhand, and Ru-Rong Ji. Resolvins RvE1 and RvD1 Attenuate Inflammatory Pain Via Central and Peripheral Actions. Nature Med. 2010; 16(5): 592-7. http://www.nature.com/nm/journal/v16/n5/full/nm.2123.html

Reference

Title
Resolvins RvE1 and RvD1 Attenuate Inflammatory Pain Via Central and Peripheral Actions
Publication
Nature Med
Publication Date
2010
Authors
Xu, Zheng-Zhong, Ling Zhang, Tong Liu, John Yeon Park, Temugin Berta, Rong Yang, Charles N Sherhand, and Ru-Rong Ji
Volume & Issue
Volume 16, Issue 5
Pages
592-7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • 60% of people with persistent back pain who turned to complementary and alternative medicine perceived a “”great deal”” of benefit.  
  • A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.  
  • Topical capsaicin was found in a meta-analysis to provide a degree of pain relief to some patients with painful neuropathic conditions.  
  • People with persistent pain who used complementary and alternative medicine (CAM) had lower average health care expenditures than nonusers ($3,797 versus $4,153).  
  • Researchers have discovered that some types of glial cells have a major impact on persistent neuropathic pain and that targeting these cells may result in a new class of disease…